Glycemia in Diabetic Elders Trial

Stopped early · Phase 4

Conditions studied: Type 2 Diabetes Mellitus

In brief

This study is a pilot randomized controlled trial of 30 elderly type 2 diabetes patients conducted at the MODEL Clinical Research (MODEL), Research Division of Bay West Endocrinology Associates in Baltimore, Maryland. The investigators hypothesized that compared to a regimen base solely on traditional drugs, a regimen including newer drugs will achieve glycemic target faster and induce less hypoglycemia, weight gain, and other side effects, over the short run.

Key facts

Study ID

NCT02029846

Run by

Johns Hopkins University

People needed

2

Starts

2013-04-01

Expected to finish

2017-02-01

Last updated by the study team

2023-04-18

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Type 2 diabetics diagnosed for at least 6 months
• Patients ages ≥ 65 years and older
• Active patients in the Bay West Endocrinology practice
• Inadequately controlled on oral agents and/or basal insulin with HbA1c between 8.0% and 12%
• Eligible for randomization to either treatment group
• Patients willing to follow either treatment arm including regimen using one or more injectables
• Patients to have an English Reading Level of Grade 6 or above
• Patients residing at home

You may not qualify if…

• Unwilling to use a regimen that may contain using one or more injections
• Using short acting insulin prior to the study
• Using GLP-1 in past 10 weeks
• History of hypoglycemia unawareness or episodes needing emergency intervention
• End-stage renal disease
• Dementia
• Blindness
• Terminal illness

Where it is running

• Bay West Endocrinology Associates — Baltimore, Maryland, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.